| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.02 | 0.9 |